Santa Monica Partners’s Psychemedics Corporation PMD Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q1 | – | Sell |
-20,000
| Closed | -$45K | – | 18 |
|
|
2024
Q4 | $45K | Hold |
20,000
| – | – | 0.02% | 17 |
|
|
2024
Q3 | $46K | Hold |
20,000
| – | – | 0.03% | 17 |
|
|
2024
Q2 | $48K | Hold |
20,000
| – | – | 0.03% | 16 |
|
|
2024
Q1 | $59K | Hold |
20,000
| – | – | 0.04% | 16 |
|
|
2023
Q4 | $59K | Hold |
20,000
| – | – | 0.04% | 16 |
|
|
2023
Q3 | $79K | Hold |
20,000
| – | – | 0.06% | 17 |
|
|
2023
Q2 | $91K | Hold |
20,000
| – | – | 0.07% | 17 |
|
|
2023
Q1 | $105K | Hold |
20,000
| – | – | 0.09% | 17 |
|
|
2022
Q4 | $98K | Hold |
20,000
| – | – | 0.07% | 18 |
|
|
2022
Q3 | $129K | Hold |
20,000
| – | – | 0.1% | 20 |
|
|
2022
Q2 | $127K | Hold |
20,000
| – | – | 0.1% | 21 |
|
|
2022
Q1 | $138K | Hold |
20,000
| – | – | 0.1% | 22 |
|
|
2021
Q4 | $140K | Hold |
20,000
| – | – | 0.09% | 21 |
|
|
2021
Q3 | $168K | Hold |
20,000
| – | – | 0.11% | 22 |
|
|
2021
Q2 | $139K | Hold |
20,000
| – | – | 0.09% | 24 |
|
|
2021
Q1 | $124K | Hold |
20,000
| – | – | 0.08% | 25 |
|
|
2020
Q4 | $102K | Buy |
+20,000
| New | +$86.8K | 0.08% | 25 |
|
Other funds holding PMD
Santa Monica Partners's PMD Position: Q1 2025 in Review
Santa Monica Partners sold out of Psychemedics Corporation (PMD) in Q1 2025, closing a stake of 20,000 shares — an estimated $45K sold.
Santa Monica Partners first reported a position in PMD in Q4 2020 and held it in 17 quarters. The position peaked at $168K in Q3 2021. 1 fund tracked by Wall St. Rank holds PMD as of Q1 2025.
- Santa Monica Partners reported no remaining Psychemedics Corporation position as of Q1 2025 after selling out during the quarter.
- Santa Monica Partners sold 20,000 Psychemedics Corporation shares in Q1 2025, an estimated $45K.
- Santa Monica Partners first reported a position in Psychemedics Corporation in Q4 2020 and held it in 17 quarters.
- Santa Monica Partners's Psychemedics Corporation position peaked at $168K in Q3 2021.
- 1 fund tracked by Wall St. Rank held Psychemedics Corporation as of Q1 2025.
Based on Santa Monica Partners's 13F filing for Q1 2025, filed 13 May 2025.